Nephros Inc (NEPH): Operating Income
$1.15M
Year ended 2025-12-31
$1.64M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.15M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $6.0K | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$1.59M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$4.33M | n/m | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | -$3.25M | n/c | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$4.28M | n/m | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | -$3.15M | n/m | 2021-03-01, From 2019-01-01 |
| 2018-12-31 | -$3.02M | n/m | 2020-02-27, From 2018-01-01 |
| 2017-12-31 | -$2.23M | n/m | 2019-03-12, From 2017-01-01 |
| 2016-12-31 | -$2.87M | n/m | 2018-02-26, From 2016-01-01 |
| 2015-12-31 | -$3.42M | n/m | 2017-03-20, From 2015-01-01 |
| 2014-12-31 | -$2.67M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$3.32M | n/m | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | -$3.33M | n/m | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | -$2.31M | n/m | 2013-03-04, From 2011-01-01 |
| 2010-12-31 | -$1.89M | n/a | 2012-03-22, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Nephros Inc (NEPH) | 2025-12-31 | $1.15M | n/m |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | -$2.46M | n/m |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | -$8.60M | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$19.89M | n/m |
| Profound Medical Corp. (PROF) | 2025-12-31 | -$41.25M | n/m |
| Biotricity Inc. (BTCY) | 2026-03-31 | $1.69M | n/m |
| DarioHealth Corp. (DRIO) | 2025-12-31 | -$36.66M | n/m |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | -$25.63M | n/m |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | -$30.16M | n/m |
Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗